John Kaiser

Biography

 Mr. Kaiser serves as Cerecor's Chief Business Officer with responsibilities for corporate strategy, strategic marketing and business development. Prior to joining Cerecor, Mr. Kaiser founded Denysias Bioscience, LLC, a biopharmaceutical company focused on developing new therapies for neuropsychiatric disorders, where he served as Chief Executive Officer. At the same time, Mr. Kaiser also served as President of Kaiser & Associates Consulting, a boutique consulting firm providing strategic corporate and commercial expertise to the biopharmaceutical industry. From 2008-2009, Mr. Kaiser served as Vice President of Commercial and Business Development at ACADIA Pharmaceuticals Inc. Before ACADIA, Mr. Kaiser held numerous positions of increasing responsibilities in sales, marketing and general management at Eli Lilly and Company in a career of more than 25 years. At Lilly, Mr. Kaiser led the global commercialization efforts of Prozac®, the global strategic marketing efforts for Cymbalta®, and helped drive the commercial success of Zyprexa® internationally. Mr. Kaiser also led the strategic marketing efforts for the company's CNS development portfolio and co-led the development and execution of the company's CNS strategy. Mr. Kaiser is a member of Cerecor's Senior Management Team and currently serves on the Board of Directors of NHTherapeutics. Mr. Kaiser received his B.S. in pharmaceutical sciences from the James L. Winkle College of Pharmacy at the University of Cincinnati.

Research Interest

Pharmaceutical sciences, Neuroscience Company, Neurological and Psychiatric Drugs